Page last updated: 2024-10-29

iohexol and Congenital Cystic Adenomatoid Malformation

iohexol has been researched along with Congenital Cystic Adenomatoid Malformation in 1 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Quarticelli, T1
Visconti, A1

Other Studies

1 other study available for iohexol and Congenital Cystic Adenomatoid Malformation

ArticleYear
[Congenital cystic adenomatoid malformation: a case report].
    La Pediatria medica e chirurgica : Medical and surgical pediatrics, 2006, Volume: 28, Issue:1-3

    Topics: Contrast Media; Cystic Adenomatoid Malformation of Lung, Congenital; Female; Humans; Infant, Newborn

2006